1990
DOI: 10.1073/pnas.87.17.6574
|View full text |Cite
|
Sign up to set email alerts
|

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Abstract: There is substantial evidence supporting the CD4 molecule as the principal cellular receptor for the human immunodeficiency virus type 1 (HIV-1). A number oftruncated recombinant soluble CD4 (sCD4) molecules have been produced and shown to easily neutralize infection of laboratory strains of HIlV-1 in vitro, and clinical trials using these sCD4 preparations have begun in patients with AIDS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

21
296
4
1

Year Published

1992
1992
2011
2011

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 424 publications
(322 citation statements)
references
References 19 publications
21
296
4
1
Order By: Relevance
“…Nef-defective virions contained higher levels of CD4 than wild-type HIV-1. Infection by HIV-1 laboratory strains (predominately X4 tropic) is more susceptible to inhibition by sCD4 than are HIV-1 primary isolates (which are normally R5 tropic) (21,49,62). We hypothesized that virion-associated CD4 more potently inhibits infection by X4-tropic viruses, thereby preferentially inhibiting replication of nef-defective X4-tropic replication.…”
Section: Vol 78 2004mentioning
confidence: 99%
“…Nef-defective virions contained higher levels of CD4 than wild-type HIV-1. Infection by HIV-1 laboratory strains (predominately X4 tropic) is more susceptible to inhibition by sCD4 than are HIV-1 primary isolates (which are normally R5 tropic) (21,49,62). We hypothesized that virion-associated CD4 more potently inhibits infection by X4-tropic viruses, thereby preferentially inhibiting replication of nef-defective X4-tropic replication.…”
Section: Vol 78 2004mentioning
confidence: 99%
“…HIV infection is blocked in vitro by recombinant sCD4 (Deen et al, 1988;Fisher et al, 1988;Hussey et al, 1988). However, sCD4 poorly neutralizes fresh isolates of HIV-1 (Daar et al, 1990;Moore et aI., 1992). This may suggest that the reduced gpl20-CD4 binding affinity is a consequence of the oligomeric organization of the env protein on intact virions (Moore et al, 1992).…”
Section: Discussionmentioning
confidence: 99%
“…Although sCD4 demonstrated efficacy against many laboratory strains, it exhibited poor activity against primary isolates (31), which may have contributed to disappointing results in clinical trials (31,32). PRO-542 (a CD4-IgG fusion protein) was shown to be effective in neutralizing many clinical HIV-1 strains in culture (15,33) and is efficacious in the clinics (16,34).…”
Section: Discussionmentioning
confidence: 99%